# US 2015/0105533 A1 · Use of polymer d-lactic acid (pdla) or equivalents thereof to inhibit growth of cancer cells and diagnose cancers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105533 A1
- Document ID: US20150105533A1
- Status: Published application
- Kind: A1
- Application number: 14/520,089
- Filed: 2014-10-21
- Published: 2015-04-16
- Earliest claimed: 2011-01-28
- Assignees: The United States of America as represented by the Department of Veterans Affairs
- Inventors: Joel S. Goldberg; Joe Brice Weinberg
- Web page: https://patentgrep.com/patent/US20150105533A1

## CPC

- C08G 63/06: derived from hydroxycarboxylic acids
- A61K 31/765: Polymers containing oxygen
- A61P 35/00: Antineoplastic agents
- C07C 59/08: Lactic acid
- C12N 5/0693: {Tumour cells; Cancer cells}
- G01N 33/5011: {for testing antineoplastic activity}
- G01N 33/57557: {of other specific parts of the body, e.g. brain}
- C12N 2533/40: Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provides method for sequestering or trapping L-lactate in or near a tumor cell comprising contacting an isolated polymer of D-lactic acid (PDLA) or an equivalent, derivative or analog thereof with the tumor cell so that the PDLA binds L-lactate in or near the cell and thereby sequestering or trapping L-lactate in or near the tumor cells.

## Claims

### Claim at position 1

1-13. (canceled)

### Claim 14

A composition comprising isolated PDLA or an equivalent, derivative or analog thereof having a molecular weight (MW) of less than 500 Daltons, wherein the composition is substantially free of PDLA having a MW greater than 500 Daltons.

### Claim 15

A composition comprising isolated PDLA or an equivalent, derivative or analog thereof having fewer than 12 monomers of D-lactic acid, wherein the composition is substantially free of PDLA having more than 12 monomers of D-lactic acid.

### Claim 16 (depends on 14)

The composition of claim 14, wherein the PDLA or an equivalent, derivative or analog thereof has fewer than 7 monomers of D-lactic acid.

### Claim 17 (depends on 16)

The composition of claim 16, wherein the composition is substantially free of PDLA or an equivalent, derivative or analog thereof having more than 7 monomers of D-lactic acid.

### Claim 18 (depends on 16)

The composition of claim 16, wherein the PDLA or an equivalent, derivative, or analog thereof has between 2 to 4 monomers of D-lactic acid.

### Claim 19 (depends on 18)

The composition of claim 18, wherein the composition is substantially free of PDLA or an equivalent, derivative or analog thereof having fewer than 2 monomers of D-lactic acid.

### Claim 20 (depends on 18)

The composition of claim 18, wherein the composition is substantially free of isolated PDLA (PDLA) or an equivalent, derivative or analog thereof having more than 4 monomers of D-lactic acid.

### Claim 21

A kit for sequestering, depleting, measuring, or detecting L-lactic acid in solution, in cell culture, in serum, in a cell, or in an animal comprising PDLA or an equivalent, derivative or analog thereof either unmodified or modified.

### Claim at position 10

22-40. (canceled)

### Claim 41 (depends on 15)

The composition of claim 15, wherein the PDLA or an equivalent, derivative or analog thereof has fewer than 7 monomers of D-lactic acid.
